RUNX2 and hepatocellular carcinoma: Our findings suggest that miR-196a mediates HCC progression by reducing the level of miRNAs targeting to the 3′-UTR of Runx2 and subsequently the downstream OPN, followed by activation of EMT regulators and stemness genes which finally lead to increased HCC invasiveness and self-renewal.